Startseite Evacuated blood-collection tubes for haematological tests – a quality evaluation prior to their intended use for specimen collection
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evacuated blood-collection tubes for haematological tests – a quality evaluation prior to their intended use for specimen collection

  • Nataša Gros EMAIL logo
Veröffentlicht/Copyright: 19. Oktober 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: An inappropriate anticoagulant concentration in a blood sample can cause cell shrinkage and affect the haematocrit and mean corpuscular volume (MCV). In evacuated blood-collection tubes there are two parameters affecting the quality of the product: the anticoagulant amount introduced into the tube during its production and the internal under-pressure at the instant of the blood-specimen collection affecting the draw-volume. No testing procedures that would give an insight into the anticoagulant concentration that can be expected for blood samples after specimen collection have been available up until now.

Methods: The methodology suggested here combines the draw-volume test performed with deionised water using a laboratory made measuring device, and a conductivity measurement. The corrections taking into account the air pressure and ambient temperature provide an insight into the anticoagulant concentration that can be expected for blood samples. Results presented in the form of a nomogram facilitate the routine use of the suggested methodology.

Results: Our 338-day study confirmed significant differences and variations in the quality and the anticoagulant concentrations of the K3EDTA and K2EDTA tubes of different producers and identified different examples of non-compliance with the norms during the shelf life of the tubes.

Conclusions: The quality evaluation of the evacuated blood-collection tubes prior to their intended use as suggested here can, in everyday laboratory practice, ensure that the tubes are used only if, and only until, their quality is adequate.


Corresponding author: Nataša Gros, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, 1000 Ljubljana, Slovenia, Phone: +386 1 2419164, Fax: +386 1 2419220

The financial support of the ARRS in the programme P1-0153 is acknowledged.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Financial support played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Goossens W, Vanduppen V, Verwilghen RL. K-2-EDTA or K-3-EDTA – the anticoagulant of choice in routine hematology. Clin Lab Haematol 1991;13:291–5.10.1111/j.1365-2257.1991.tb00284.xSuche in Google Scholar

2. Banfi G, Salvagno GL, Lippi G. The role of ethylenedimine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med 2007;45:565–76.10.1515/CCLM.2007.110Suche in Google Scholar

3. NCCLS. Tubes and additives for venous blood specimen collection, 5th ed. NCCLS document H1-A5. Wayne, Pennsylvania: NCCLS, 2003.Suche in Google Scholar

4. Plebani M. Appropriateness in programs for continuous quality improvement in clinical laboratories. Clin Chim Acta 2003;333:131–9.10.1016/S0009-8981(03)00177-3Suche in Google Scholar

5. Howanitz PJ. Errors in laboratory medicine – Practical lessons to improve patient safety. Arch Pathol Lab Med 2005;129:1252–61.10.5858/2005-129-1252-EILMPLSuche in Google Scholar PubMed

6. Signori C, Ceriotti F, Sanna A, Plebani M, Messeri G, Ottomano C, et al. Process and risk analysis to reduce errors in clinical laboratories. Clin Chem Lab Med 2007;45:742–8.10.1515/CCLM.2007.172Suche in Google Scholar PubMed

7. Sciacovelli L, Plebani M. The IFCC Working Group on laboratory errors and patient safety. Clin Chim Acta 2009;404:79–85.10.1016/j.cca.2009.03.025Suche in Google Scholar PubMed

8. Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997;43:1348–51.10.1093/clinchem/43.8.1348Suche in Google Scholar

9. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691–8.10.1093/clinchem/48.5.691Suche in Google Scholar

10. Carraro P, Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 2007;53:1338–42.10.1373/clinchem.2007.088344Suche in Google Scholar PubMed

11. Banfi G, Dolci A. Preanalytical phase of sport biochemistry and haematology. J Sports Med Phys Fit 2003;43:223–30.Suche in Google Scholar

12. Ashakiran S, Sumati ME, Murthy NK. A study of pre-analytical variables in clinical biochemistry laboratory. Clin Biochem 2011;44:944–5.10.1016/j.clinbiochem.2011.05.003Suche in Google Scholar PubMed

13. Wallin O, Soderberg J, Van Guelpen B, Brulin C, Grankvist K. Patient-centred care – preanalytical factors demand attention: a questionnaire study of venous blood sampling and specimen handling. Scand J Clin Lab Invest 2007;67:836–47.10.1080/00365510701370675Suche in Google Scholar PubMed

14. Wallin O, Soderberg J, Van Guelpen B, Stenlund H, Grankvist K, Brulin C. Preanalytical venous blood sampling practices demand improvement – A survey of test-request management, test-tube labelling and information search procedures. Clin Chim Acta 2008;391:91–7.10.1016/j.cca.2008.02.016Suche in Google Scholar PubMed

15. Kratz A, Salem RO, Van Cott EM. Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med 2007;131:293–6.10.5858/2007-131-293-EOAPTSSuche in Google Scholar PubMed

16. Wallin O, Soderberg J, Grankvist K, Jonsson PA, Hultdin J. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation. Clin Chem Lab Med 2008;46:1443–9.10.1515/CCLM.2008.288Suche in Google Scholar PubMed

17. Tatsumi N, Miwa S, Lewis SM. Specimen collection, storage, and transmission to the laboratory for hematological tests. Int J Hematol 2002;75:261–8.10.1007/BF02982039Suche in Google Scholar PubMed

18. Salvagno GL, Lippi G, Solero GP, Montagnana M, Franchini M, Gelati M, et al. Influence of primary tube mixing on hematological testing. Clin Chem 2007;53:A128–9.Suche in Google Scholar

19. Lippi G, Salvagno GL, Brocco G, Guidi GC. Preanalytical variability in laboratory testing: influence of the blood drawing technique. Clin Chem Lab Med 2005;43:319–25.10.1515/CCLM.2005.055Suche in Google Scholar PubMed

20. Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Poli G, Solero GP, et al. K3EDTA vacuum tubes validation for routine hematological testing. ISRN Hematol 2012;2012:5.10.5402/2012/875357Suche in Google Scholar PubMed PubMed Central

21. Sottas PE, Robinson N, Rabin O, Saugy M. The athlete biological passport. Clin Chem 2011;57:969–76.10.1373/clinchem.2011.162271Suche in Google Scholar PubMed

22. Gilbert S. The biological passport. Hastings Center Rep 2010;40:18–9.10.1353/hcr.0.0235Suche in Google Scholar PubMed

23. Malcovati L, Pascutto C, Cazzola M. Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 2003;88:570–81.Suche in Google Scholar

24. Schumacher YO, Schmid A, Lenz T, Keul J. Blood testing in sports: hematological profile of a convicted athlete. Clin J Sport Med 2001;11:115–7.10.1097/00042752-200104000-00009Suche in Google Scholar PubMed

25. Pialoux V, Mounier R, Brugniaux JV. Hemoglobin and hematocrit are not such good candidates to detect autologous blood doping. Int J Hematol 2009;89:714–5.10.1007/s12185-009-0330-5Suche in Google Scholar PubMed

26. Lombardi G, Lanteri P, Colombini A, Lippi G, Banfi G. Stability of haematological parameters and its relevance on the athlete’s biological passport model. Sports Med 2011;41:1033–42.10.2165/11591460-000000000-00000Suche in Google Scholar PubMed

27. Robinson N, Sottas PE, Mangin P, Saugy M. Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica 2007;92:1143–4.10.3324/haematol.11182Suche in Google Scholar PubMed

28. Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M. Stability and robustness of blood variables in an antidoping context. Int J Lab Hematol 2011;33:146–53.10.1111/j.1751-553X.2010.01256.xSuche in Google Scholar PubMed

29. Ashenden M, Gough CE, Garnham A, Gore CJ, Sharpe K. Current markers of the athlete blood passport do not flag microdose EPO doping. Eur J Appl Physiol 2011;111:2307–14.10.1007/s00421-011-1867-6Suche in Google Scholar PubMed

30. NBSIR 74-461. The calibration of small volumetric laboratory glassware. December 1974.Suche in Google Scholar

31. DIN ISO 6710: 1996-12 Single-use containers for venous blood specimen collection. 1996.Suche in Google Scholar

Received: 2012-8-6
Accepted: 2012-9-14
Published Online: 2012-10-19
Published in Print: 2013-05-01

©2013 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Progress towards standardization: an IFCC Scientific Division Perspective
  5. Review
  6. Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application
  7. Mini Reviews
  8. Analytical goals for the determination of HbA2
  9. Glucose meters – fit for clinical purpose
  10. Opinion Papers
  11. Metrological traceability – a concept for standardization in laboratory medicine
  12. Recommendations for clinical laboratory science reports regarding properties, units, and symbols: the NPU format1)
  13. “Good samples make good assays” – the problem of sourcing clinical samples for a standardization project
  14. Defining acceptable limits for the metrological traceability of specific measurands
  15. Original Articles
  16. A reference system for urinary albumin: current status
  17. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible
  18. External Quality Assessment Scheme for reference laboratories – review of 8 years’ experience
  19. Utility of a panel of sera for the alignment of test results in the worldwide multicenter study on reference values
  20. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values
  21. Guidelines and Recommendations
  22. 2013 update on the worldwide standardization of the hemoglobin A1c measurement
  23. General Clinical Chemistry and Laboratory Medicine
  24. Evacuated blood-collection tubes for haematological tests – a quality evaluation prior to their intended use for specimen collection
  25. Refrigeration is not necessary for measurement of uric acid in patients treated with rasburicase
  26. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis
  27. Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics
  28. Helicobacter pylori serology in autoimmune diseases – fact or fiction?
  29. Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement
  30. Antibodies against Nε-homocysteinylated proteins in patients on different methods of renal replacement therapy
  31. Reference Values and Biological Variations
  32. Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform
  33. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis
  34. Cardiovascular Diseases
  35. Circulating matrix Gla protein: a potential tool to identify minor carotid stenosis with calcification in a risk population
  36. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study
  37. Letters to the Editor
  38. Relationship between Helicobacter pylori infection and autoimmune disorders
  39. Rapid simultaneous genotyping of polymorphisms in ADH1B and ALDH2 using high resolution melting assay
  40. Comparison of biological specimens and DNA collection methods for PCR amplification and microarray analysis
  41. Transferrin/log(ferritin) ratio: a self-fulfilling prophecy when iron deficiency is defined by serum ferritin concentration
  42. Response to: Transferrin/log(ferritin) ratio: a self-fulfilling prophecy when iron deficiency is defined by serum ferritin concentration
  43. Determinants of homocysteine concentrations in mother and neonatal girl pairs
  44. Cysteine analog breaks cryoprecipitate associated with chronic hepatitis C
  45. Cut-off values of serum growth hormone (GH) in pharmacological stimulation tests (PhT) evaluated in short-statured children using a chemiluminescent immunometric assay (ICMA) calibrated with the International Recombinant Human GH Standard 98/574
  46. Normalized MEDx chart as a useful tool for evaluation of analytical quality achievements. A picture is worth a thousand words
  47. Harmonization of immunoassays to the all-procedure trimmed mean – proof of concept by use of data from the insulin standardization project
  48. Congress Abstracts
  49. Annual Assembly of the Swiss Society of Clinical Chemistry & International Congress of Porphyrins and Porphyrias & International Meeting of Porphyria Patients: Personalized Medicine and Rare Diseases
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0507/html
Button zum nach oben scrollen